Extension of organised cervical cancer screening programmes in Italy and their process indicators: 2008 activity

被引:0
|
作者
Ronco, Guglielmo [1 ]
Giubilato, Pamela [1 ]
Naldoni, Carlo
Zorzi, Manuel [2 ]
Anghinoni, Emanuela [3 ]
Scalisi, Aurora [9 ]
Dalla Palma, Paolo [4 ]
Zanier, Loris [5 ]
Barca, Alessandra [6 ]
Angeloni, Claudio [7 ]
Gaimo, Maria Donata
Maglietta, Rocco
Mancini, Ettore [1 ]
Pizzuti, Renato
Iossa, Anna [8 ]
Segnan, Nereo [1 ]
Zappa, Marco [8 ]
机构
[1] CPO Piemonte, Turin, Italy
[2] IOV IRCCS, Registro Tumori Veneto, Padua, Italy
[3] ASL Mantova, Mantua, Italy
[4] Osped Trento, Trento, Italy
[5] ASP Friuli Venezia Giulia, Trieste, Italy
[6] ASP Lazio, Rome, Italy
[7] ASL Teramo, Teramo, Italy
[8] ISPO, UO Epidemiol Clin & Descritt, Florence, Italy
[9] Screening Citol Catania, Catania, Italy
来源
EPIDEMIOLOGIA & PREVENZIONE | 2010年 / 34卷 / 5-6期
关键词
cervical cancer screening programmes; Italy; HUMAN-PAPILLOMAVIRUS;
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Italian national guidelines recommend to Regions the implementation of organised screening programmes for cervical cancer. As in previous years since 1998, we collected from Italian organised cervical screening programmes aggregated tables of data in order to centrally compute process indicators. Data on women invited during 2008 and screened up to April 2009 were considered. In 2008, the target population of Italian organised screening programmes included 13,094,025 women, corresponding to 78.4% of Italian women aged 25-64 years. Compliance to invitation was 39.7%, with a strong North-South decreasing trend. However, it should be considered that many women are screened outside the organised programmes. Of the women screened, 5.2% were referred for repeat cytology and 63.0% of them complied; 2.4% of screened women were referred to colposcopy. Compliance with colposcopy referral was 85.1% among women referred because of ASCUS or more severe cytology and 89.3% among those referred because of HSIL or more severe cytology The positive predictive value (PPV) of referral because of ASCUS or more severe cytology for CIN2 or more severe histology was 16.0%. The unadjusted detection rate of CIN2 or more severe histology was 3.1 per 1,000 screened women (3.0 standardised on the Italian population, truncated 25-64).
引用
收藏
页码:35 / 51
页数:17
相关论文
共 50 条
  • [41] Impact of organised cervical screening on cervical cancer incidence and mortality in migrant women in Australia
    Aminisani, Nayyereh
    Armstrong, Bruce K.
    Egger, Sam
    Canfell, Karen
    BMC CANCER, 2012, 12
  • [42] Estimating the impact of an organised screening programme on cervical cancer incidence: A 26-year study from northern Italy
    Bucchi, Lauro
    Baldacchini, Flavia
    Mancini, Silvia
    Ravaioli, Alessandra
    Giuliani, Orietta
    Vattiato, Rosa
    Falcini, Fabio
    Rossi, Paolo Giorgi
    Campari, Cinzia
    Canuti, Debora
    Di Felice, Enza
    de Bianchi, Priscilla Sassoli
    Ferretti, Stefano
    Bertozzi, Nicoletta
    Biggeri, Annibale
    Bertozzi, Nicoletta
    Di Felice, Enza
    Ferretti, Stefano
    Finarelli, Alba Carola
    Naldoni, Carlo
    de Bianchi, Priscilla Sassoli
    Baldacchini, Flavia
    Bucchi, Lauro
    Giuliani, Orietta
    Mancini, Silvia
    Ravaioli, Alessandra
    Vattiato, Rosa
    Falcini, Fabio
    Borciani, Elisabetta
    Dataro, Pier Giorgio
    Gatti, Giorgio
    Lauri, Alessandro
    Lombardozzi, Luigi
    Michiara, Maria
    Mangone, Lucia
    Campari, Cinzia
    Paterlini, Luisa
    Rubino, Teresa
    Andresini, Raffaella
    Carrozzi, Giuliano
    Corradini, Rossella
    Goldoni, Carlo Alberto
    Venturelli, Agar
    Vezzani, Maria Dirce
    Bazzani, Carmen
    Biavati, Patrizia
    Cristiani, Paolo
    Manfredi, Marilena
    Mezzetti, Francesca
    Pasquini, Adriana
    INTERNATIONAL JOURNAL OF CANCER, 2019, 144 (05) : 1017 - 1026
  • [43] Should breast cancer survivors be excluded from, or invited to, organised mammography screening programmes?
    Lauro Bucchi
    BMC Health Services Research, 11
  • [44] Human Papillomavirus Types Distribution in Organised Cervical Cancer Screening in France
    Heard, Isabelle
    Tondeur, Laura
    Arowas, Laurence
    Res, Michael Falguie
    Demazoin, Marie-Christine
    Favre, Michel
    PLOS ONE, 2013, 8 (11):
  • [45] Organised screening for cervical cancer in France: a cost-effectiveness assessment
    Barre, Stephanie
    Massetti, Marc
    Leleu, Henri
    De Bels, Frederic
    BMJ OPEN, 2017, 7 (10):
  • [46] SURVEY OF PARTICIPATION IN ORGANISED CERVICAL CANCER-SCREENING PROGRAMME IN HUNGARY
    Gyulai, Aniko
    Nagy, Attila
    Pataki, Vera
    Tonte, Dora
    Adany, Roza
    Voko, Zoltan
    CENTRAL EUROPEAN JOURNAL OF PUBLIC HEALTH, 2015, 23 (04) : 360 - 364
  • [47] Should breast cancer survivors be excluded from, or invited to, organised mammography screening programmes?
    Bucchi, Lauro
    BMC HEALTH SERVICES RESEARCH, 2011, 11
  • [48] Screening for colorectal cancer in Italy: 2008 survey
    Zorzi, Manuel
    Baracco, Susanna
    Fedato, Chiara
    Grazzini, Grazia
    Naldoni, Carlo
    de' Bianchi, Priscilla Sassoli
    Senore, Carlo
    Visioli, Carmen Beatriz
    Cogo, Carla
    EPIDEMIOLOGIA & PREVENZIONE, 2010, 34 (5-6): : 53 - 72
  • [49] IN ITALY, MORE AND MORE WOMEN UNDERTAKE TESTS FOR EARLY DIAGNOSIS OF CERVICAL CANCER WITHIN ORGANIZED SCREENING PROGRAMMES
    Carrozzi, Giuliano
    Sampaolo, Letizia
    Bolognesi, Lara
    Bertozzi, Nicoletta
    Ferrante, Gianluigi
    Minardi, Valentina
    Masocco, Maria
    Epidemiologia & Prevenzione, 2016, 40 (06): : 476 - 476
  • [50] Cervical cancer screening at a turning point in Italy
    Franceschi, Silvia
    EPIDEMIOLOGIA & PREVENZIONE, 2012, 36 (3-4): : 142 - 144